Research is exploring the molecular mechanisms of tumor development in glioblastoma, with some studies suggesting a potential role for the circadian clock. The disease is being examined from various angles, including the metabolism and epigenetics of glioma cells, as well as the interactions between glioma cells and the immune system. These investigations may uncover new therapeutic targets and approaches for treating glioblastoma.